Delivery Order SPE2DB24D2212-SPE2DB25FHQUB
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,005.97 delivery order on August 27, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count). This competitively awarded, firm fixed-price contract requires performance at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. No set-aside provisions were applied to this award. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $2,891.34 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dexmethylphenidate ER 15 mg capsules (100 count). The contract is firm fixed price with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child delivery order under a larger contract...
- AmerisourceBergen Drug Corp was awarded a $7,935.15 delivery order by the Defense Logistics Agency's Medical Supply Chain on August 8, 2025, for the supply of Dexmethylphenidate ER Capsules 25mg. This is a firm fixed-price, non-set-aside contract with performance to be completed by August 11, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for dexmethylphenidate ER 25 mg capsules (100-count) on August 20, 2025, with a ceiling value of $1,011.21. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this order, which is structured as a child contract under a...
- The Defense Logistics Agency awarded a $1,419.38 delivery order to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 15 mg capsules (100-count bottles) on July 28, 2025, with completion targeted for July 29, 2025. This non-set-aside, firm fixed-price contract represents a single delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Dexmethylphenidate ER Capsules 25mg, valued at $4,752.45 under a firm fixed-price contract. This non-set-aside award represents a routine pharmaceutical procurement to support military and federal healthcare operations. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Dexmethylphenidate Extended Release 10 mg capsules (100-count bottles) with a ceiling value of $1,433.11. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was competitively evaluated. The ultimate completion date is August 22, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Dexmethylphenidate ER Capsules 25mg, with a contract ceiling value of $5,748.70. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an open competition process. The contract is scheduled for ultimate completion by August 13, 2025, with performance taking place at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,143.20 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 25 mg capsules (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. This competitive, non-set-aside delivery order utilizes firm fixed price terms and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,605.70 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 30 mg capsules (100 count). This competitively awarded contract, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB25FHQUBDelivery Order
The Defense Logistics Agency awarded a $5,864.53 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count). This is a firm fixed price, non-set-aside contract with a completion date of September 11, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a competitive award under AmerisourceBergen's existing contract vehicle with DLA. This award is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a substantial $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for Defense Health Agency and other military healthcare programs. The company's contract portfolio demonstrates extensive experience delivering both brand-name and generic medications across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 9/10/25 |